Drugs Affecting Growth of Tumours

  • Herbert M. Pinedo
  • Carolien H. Smorenburg

Part of the Milestones in Drug Therapy book series (MDT)

Table of contents

  1. Front Matter
    Pages I-IX
  2. Kenneth W. Wyman, Igor Puzanov, Kenneth R. Hande
    Pages 1-18
  3. Klaus Mross, Ulrich Massing, Felix Kratz
    Pages 19-81
  4. Hans Gelderblom, Alex Sparreboom
    Pages 83-100
  5. Manon T. Huizing
    Pages 101-131
  6. Alfonsus J. M. van den Eertwegh
    Pages 133-151
  7. Carolien H. Smorenburg1, Alex Sparreboom
    Pages 153-166
  8. Bart C. Kuenen
    Pages 167-183
  9. Ferry A. L. M Eskens
    Pages 185-199
  10. Rosalba Torrisi, Alessandra Balduzzi, Aron Goldhirsch
    Pages 201-230
  11. Back Matter
    Pages 231-237

About this book


During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds.

This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics.


Anti-cancer Drugs New Drug Targets Therapy of Cancer Tumour Growth angiogenesis breast cancer cancer chemotherapy drug research signal transduction tumor tumors vaccination

Editors and affiliations

  • Herbert M. Pinedo
    • 1
  • Carolien H. Smorenburg
    • 1
  1. 1.Department of Medical OncologyVU Medical CenterAmsterdamThe Netherlands

Bibliographic information